EPH Receptor A4 Antikörper (C-Term)

Produktnummer ABIN2469317

Der Kaninchen Polyklonal Anti-EPH Receptor A4-Antikörper wurde für ELISA und IHC validiert. Er ist geeignet, EPH Receptor A4 in Proben von Human, Maus, Ratte, Rind (Kuh), Hund, Affe, Kaninchen, Pferd, Schwein, Fledermaus, Hamster, Gibbon und Gorilla zu detektieren.

Kurzübersicht für EPH Receptor A4 Antikörper (C-Term) (ABIN2469317)

Target: EPH Receptor A4 (EPHA4)

Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Affe, Kaninchen, Pferd, Schwein, Fledermaus, Hamster, Gibbon, Gorilla

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser EPH Receptor A4 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC)

Produktdetails anti-EPH Receptor A4 Antikörper

Bindungsspezifität: C-Term

Spezifität: BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Aufreinigung: Immunoaffinity Chromatography

Immunogen: EPHA4 antibody was raised against a peptide located in the C-Terminal domain of EPHA4 (Human).

Anwendungsinformationen

Applikationshinweise: EPHA4 antibody can be used in immunohistochemistry starting at 7.3 μg/mL.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS, 0.1 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: As with all antibodies avoid freeze/thaw cycles.

Lagerung: 4 °C/-80 °C

Informationen zur Lagerung: EPHA4 antibody should be stored long term (months) at -80 °C and short term (days) at 4 °C.

Details zu EPH Receptor A4

Target: EPH Receptor A4 (EPHA4)

Andere Bezeichnung: EPHA4

Hintergrund: Nak1, a NR4 Nerve Growth Factor-Like receptor, has been shown to affect the hypothalamic-pituitary axis, neuronal differentiation, neuroendocrine regulation of adrenocortical function, and T-cell apoptosis. Nak1 also is known as nuclear receptor Tr3 and is similar to mouse Nur77 and rat NGFI-B. It is encoded by one of the immediate early genes (IEG) in response to nerve growth factor and other serum growth factors. Nak1 can bind to DNA as a monomer, homodimer, or heterodimer (with retinoid X receptors). Nak1 has been shown to inhibit vascular lesion formation and could serve as a novel target in the treatment of vascular diseases.

Gen-ID: 2043

UniProt: P54764

Pathways: RTK Signalweg